HF
BCRX icon

Halpern Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History

Halpern Financial’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,200
Closed -$16.4K – 255
2020
Q4 		$16.4K Hold
2,200
– – 0.01% 91
2020
Q3 		$7.56K Hold
2,200
– – ﹤0.01% 127
2020
Q2 		$10.5K Buy
+2,200
New +$10.5K 0.01% 97